| Financial Year |
March 31 2022 |
| Monetary Funds |
133,502,724.82 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,009,400.00 |
| Accounts Receivable |
1,239,135,199.19 |
| Advances to Suppliers |
95,207,791.24 |
| Other Receivables |
23,210,413.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
271,910,401.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
27,317,880.96 |
| Total Current Assets |
1,857,207,571.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
6,991,908.64 |
| Long-term Equity Investment |
88,496,786.79 |
| Investment Properties |
147,783,718.93 |
| Fixed Assetes |
496,404,303.84 |
| Under-construction Projects |
120,393,012.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
137,682,085.91 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,260,384.46 |
| Deferred Income Tax Assets |
16,225,375.46 |
| Other Non-Current Assets |
30,916,039.81 |
| Sub-Total of Non-Current Assets |
1,220,353,976.31 |
| Total Assets |
3,077,561,548.16 |
| Short-Term Loans |
524,901,493.08 |
| Trading Financial liabilities |
-- |
| Notes Payable |
13,875,000.00 |
| Accounts Payable |
566,371,835.33 |
| Accounts Received In Advance |
1,946,371.05 |
| Employee Compensation Payable |
30,960,561.97 |
| Taxes Payable |
19,328,075.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
248,070,349.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,511,348.10 |
| Other Current Liabilities |
6,445,321.72 |
| Sub-Total of Current Liabilities |
1,446,272,062.16 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
25,652,161.33 |
| Deferred Income Tax Liabilities |
25,852,876.70 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
141,382,140.16 |
| Total Liabilities |
1,587,654,202.32 |
| Paid-In Capital(Or Share Stock) |
1,136,400,000.00 |
| Capital Surplus |
491,951,141.38 |
| Surplus Reserve |
34,558,636.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-217,772,676.53 |
| Minority Stockholder's Interest |
-6,432,525.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,496,339,871.26 |
| Owner's Equity（Stockholder's Equity） |
1,489,907,345.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,077,561,548.16 |
